Revealing the Determinants of Widespread Alternative Splicing Perturbation in Cancer

Yongsheng Li1, Nidhi Sahni2, Rita Pancsa3

  • 1Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; College of Bioinformatics Science and Technology and Bio-Pharmaceutical Key Laboratory of Heilongjiang Province, Harbin Medical University, Harbin 150081, China.

Cell Reports
|October 19, 2017
PubMed

Insights

Cancer mutations alter gene splicing, impacting immune response and cell growth. This study links specific mutations to splicing changes, revealing new cancer subtypes and potential precision medicine targets.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Alternative splicing generates functional diversity crucial for cancer.
  • Mechanisms linking cancer mutations to splicing alterations are largely unknown.

Purpose of the Study:

  • To develop a network-based strategy to link somatic mutations with cancer-specific splicing events.
  • To investigate the functional impact of mutation-driven splicing perturbations across cancer types.

Main Methods:

  • Developed DrAS-Net, a network-based strategy.
  • Analyzed over 2.5 million variants across 33 cancer types.
  • Inferred functional impact of deregulated splicing targets.

Main Results:

  • Identified over 40,000 driver variant candidates and 80,000 splicing targets.
  • Observed reduced immune gene expression and increased proliferation markers in tumors with splicing perturbations.
  • Found distinct splicing alterations for different mutations within the same gene.
  • Stratified 10,000 patients into subtypes with distinct clinical features, including survival rates.

Conclusions:

  • Single-nucleotide changes can significantly alter splicing isoform repertoires in cancer.
  • Mutation-splicing relationships provide insights into oncogenic mechanisms.
  • Findings support the development of precision medicine strategies targeting splicing alterations.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.8K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.4K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.2K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.3K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

7.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K